Concepedia

Vianihuini Figueroa-Vazquez

VF

Statistics

Publications

4

Citations

157

H-Index

4

Active since

2013

Affiliations

German Cancer Research Center(Current)

Heidelberg University

Heidelberg Pharma (Germany)

University Hospital Heidelberg

Vianihuini Figueroa-Vazquez is an author at German Cancer Research Center specializing in molecular oncology, oncology, and medicine.

Publications per year

2013–2020

4

Publications

4

HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells

Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig et al. · Molecular Cancer Therapeutics · 2020 · 78 citations · Full text

Medicine, Oncology, Pharmacology +13

Micro<scp>RNA</scp> signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Beatriz Sánchez‐Espiridión, Ana M. Martín‐Moreno, Carlos Montalbán et al. · British Journal of Haematology · 2013 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +17

THREE-DIMENSIONAL MAPPING OF DIFFERENTIAL AMINO ACIDS OF HUMAN, MURINE, CANINE AND EQUINE TLR4/MD-2 RECEPTOR COMPLEXES CONFERRING ENDOTOXIC ACTIVATION BY LIPID A, ANTAGONISM BY ERITORAN AND SPECIES-DEPENDENT ACTIVITIES OF LIPID IVA IN THE MAMMALIAN LPS SENSOR SYSTEM

Thomas Scior, Jorge Lozano-Aponte, Vianihuini Figueroa-Vazquez et al. · Computational and Structural Biotechnology Journal · 2013 · 21 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Jonathan Ko, Christian Breunig, Vianihuini Figueroa-Vazquez et al. · Blood · 2017 · 14 citations

Medicine, Oncology, Pharmacology +16

1–4 of 4